Author

Simge Acar

Washington University in St. LouisORCID 0000-0002-9757-5059Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Angela C. HirbeiD· 1 shared Belinda B. GaranaiD· 1 shared Chelsea M. Hutchinson-BunchiD· 1 shared Christine A. PratilasiD· 1 shared Dana C. BorcherdingiD· 1 shared Gorkem OztosuniD· 1 shared Jiawan JC Wang· 1 shared Marina A. GritsenkoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angela C. HirbeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multi-omics integration of malignant peripheral nerve sheath tumors identifies potential targets based on chromosome 8q status

Belinda B. Garana, Jiawan JC Wang, Simge Acar, Gorkem Oztosun, Stavriani C. Makri, Dana C. Borcherding, Ying S. Zou, Chelsea M. Hutchinson-Bunch, Marina A. Gritsenko, Paul Piehowski, Christine A. Pratilas, Angela C. Hirbe, Sara J.C. Gosline

This study integrates multi-omics data from MPNSTs to identify drug targets based on chromosome 8q status, suggesting PLK1 and EGFR inhibitors could be effective in different subtypes.

bioRxiv · Jan 27, 2026 · PreprintCancer Biology